Asthma costs extend well beyond the emergency department, into lost schooling, reduced earning potential, and steroid harm, which sharpens the case for recognizing uncontrolled disease and escalating care promptly.
Geoffrey Chupp, MD
Advertisement
Geoffrey Chupp, MD, is a pulmonologist who specializes in lung diseases that affect the airway, including severe asthma, Chronic Obstructive Pulmonary Disease (COPD), bronchiolitis, autoimmune airway diseases, and airway diseases that have not been classified.
Articles by Geoffrey Chupp, MD
Most patients with asthma carry a type 2 inflammatory signature, and the sickest fifth of them account for the bulk of an $80 billion annual burden.
Geoffrey Chupp, MD, explains how IL-5 and IL-4Rα biologics are reshaping COPD care and why eosinophil requirements still limit access.
Geoffrey Chupp, MD, of Yale Medicine explains how a blood RNA study shows T2-low asthma is more complex than clinicians generally think.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
Perspectives on Health-Related Social Needs for Medicare Advantage Beneficiaries
3
FDA Approves First Heart Valve to Keep Pace With Children's Growth
4
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
5